#BEGIN_DRUGCARD DB01593

# AHFS_Codes:
40:12.00
84:24.12
84:80.00
84:92.00
88:29.00*
92:02.00*

# ATC_Codes:
A12CB01
A12CB02
A12CB03
A12CB20
A16AX05
B05XA12
C05AX04
D09AB01
D11AX12
S01AX03

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
7440-66-6

# ChEBI_ID:
30185

# Chemical_Formula:
Zn

# Chemical_IUPAC_Name:
zinc

# Chemical_Structure:
Not Available

# Creation_Date:
2007-08-29 10:03:04 -0600

# DPD_Drug_ID_Number:
42595

# Description:
A metallic element of atomic number 30 and atomic weight 65.38. It is a necessary trace element in the diet, forming an essential part of many enzymes, and playing an important role in protein synthesis and in cell division. Zinc deficiency is associated with anemia, short stature, hypogonadism, impaired wound healing, and geophagia. It is known by the symbol Zn.

# Dosage_Forms:
Aerosol	Oral
Capsule	Oral
Cream	Topical
Dressing	Topical
Liquid	Oral
Liquid	Sublingual
Liquid	Topical
Lotion	Topical
Lozenge	Oral
Ointment	Rectal
Ointment	Topical
Paste	Topical
Powder	Oral
Powder	Topical
Solution	Intravenous
Solution / drops	Oral
Suppository	Rectal
Tablet	Oral
Tablet, extended release	Oral

# Drug_Category:
Trace Elements

# Drug_Interactions:
Ciprofloxacin	Formation of non-absorbable complexes
Deferiprone	Deferiprone serum concentrations may be decreased by zinc salts except for zinc chloride.
Demeclocycline	Formation of non-absorbable complexes
Doxycycline	Formation of non-absorbable complexes
Gatifloxacin	Formation of non-absorbable complexes
Gemifloxacin	Formation of non-absorbable complexes
Grepafloxacin	Formation of non-absorbable complexes
Levofloxacin	Formation of non-absorbable complexes
Minocycline	Formation of non-absorbable complexes
Moxifloxacin	Formation of non-absorbable complexes
Norfloxacin	Formation of non-absorbable complexes
Ofloxacin	Formation of non-absorbable complexes
Tetracycline	Formation of non-absorbable complexes
Trovafloxacin	Zinc may decrease the absorption of orally administered Trovafloxacin. Administer Trovafloxacin 2 hours before or 6 hours after a dose of the zinc containing agent to minimize the interaction.

# Drug_Reference:
Not Available

# Drug_Type:
Approved
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Zinc

# HET_ID:
Not Available

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/Zn

# InChI_Key:
InChIKey=HCHKCACWOHOZIP-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C00038

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
1593

# Mechanism_Of_Action:
Not Available

# Melting_Point:
419.5 Â°C

# Molecular_Weight_Avg:
65.409

# Molecular_Weight_Mono:
63.929146578

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
PA451956

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
0

# Predicted_LogS:
0

# Predicted_Water_Solubility:
Not Available

# Primary_Accession_No:
DB01593

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
23994

# PubChem_Substance_ID:
46506903

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
Not Available

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
[Zn]

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:18 -0700

# Wikipedia_Link:
http://en.wikipedia.org/wiki/Zinc

# pKa_Isoelectric_Point:
Not Available

#END_DRUGCARD DB01593
